SEC Filing Record

Offering Amount

Indefinite

Strategy

VC

Exemption

06b

Date Filed

May 19, 2026

0002134809-26-000001

View on SEC EDGAR →

37A Read

The $0 offering is a placeholder filing under Rule 506(b), indicating the manager is still finalizing LP commitments and fund terms before disclosing a target size; the absence of named GPs and any prior EDGAR history suggests this is either a newly formed manager entity or a first-time filer operating under a holding structure not yet visible in public records.

With no prior fund filings traceable to this manager on EDGAR, this vehicle signals either a new GP launching their debut fund, a previously private manager now filing for the first time, or an established operator using a newly formed entity to compartmentalize this biotech-focused strategy from other vehicles or LPs.

Filing in May 2026 aligns with post-IPO biotech volatility and renewed LP appetite for life-sciences venture after 2024–2025 correction cycles; a biotech-specific fund launched at this inflection point targets LPs rotating back into sector-specific exposure rather than generalist platforms.

Before engagement, verify whether the $0 placeholder will be updated with a final target within 90 days (standard practice post-filing) and confirm the manager's actual legal entity structure and any key-person dependencies, since the lack of named GPs on this filing creates ambiguity about fund control and decision-making authority.

Full analysis (GP structure, exemption breakdown, and market context) is available to Pro members.

Unlock Pro · $29/month → Sign in

Principals

Registered Manager

NSG BioInnovation Fund GP, LLC

NSG BioInnovation Fund, L.P.